{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:03:46Z","timestamp":1777982626290,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100010340","name":"Lebanese American University","doi-asserted-by":"publisher","award":["PIRF Grant # I0026"],"award-info":[{"award-number":["PIRF Grant # I0026"]}],"id":[{"id":"10.13039\/100010340","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01370-8","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:35:09Z","timestamp":1774870509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arginine deprivation induces ROS dependent autophagic cell death in human acute myeloid leukemia cells"],"prefix":"10.1007","volume":"39","author":[{"given":"Fatima","family":"Taki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirna","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oula","family":"El-Atat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Al-Samman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9587-7758","authenticated-orcid":false,"given":"Ralph J.","family":"Abi-Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"7","key":"1370_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","volume":"6","author":"I De Kouchkovsky","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood Cancer J. 2016;6(7):e441.","journal-title":"Blood Cancer J"},{"issue":"1","key":"1370_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"J Prada-Arismendy","year":"2017","unstructured":"Prada-Arismendy J, Arroyave JC, R\u00f6thlisberger S. Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2017;31(1):63\u201376.","journal-title":"Blood Rev"},{"key":"1370_CR3","doi-asserted-by":"publisher","unstructured":"Cancer statistics, 2024 - Siegel - 2024 - CA: A Cancer Journal for Clinicians - Wiley Online Library [Internet]. [cited 2024 Jul 25]. Available from: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.3322\/caac.21820","DOI":"10.3322\/caac.21820"},{"key":"1370_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70\u201387.","journal-title":"Blood Rev"},{"issue":"1","key":"1370_CR5","first-page":"8","volume":"2","author":"RJ Haines","year":"2010","unstructured":"Haines RJ, Pendleton LC, Eichler DC. Argininosuccinate synthase: at the center of arginine metabolism. Int J Biochem Mol Biol. 2010;2(1):8\u201323.","journal-title":"Int J Biochem Mol Biol"},{"issue":"388","key":"1370_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.canlet.2016.11.028","volume":"1","author":"Y Long","year":"2017","unstructured":"Long Y, Tsai WB, Wang D, Hawke DH, Savaraj N, Feun LG, et al. Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy. Cancer Lett. 2017;1(388):54\u201363.","journal-title":"Cancer Lett"},{"issue":"25","key":"1370_CR7","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","volume":"115","author":"CP Hernandez","year":"2010","unstructured":"Hernandez CP, Morrow K, Lopez-Barcons LA, Zabaleta J, Sierra R, Velasco C, et al. Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood. 2010;115(25):5214\u201321.","journal-title":"Blood"},{"issue":"6","key":"1370_CR8","first-page":"1495","volume":"25","author":"A Manca","year":"2011","unstructured":"Manca A, Sini MC, Izzo F, Ascierto PA, Tatangelo F, Botti G, et al. Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. Oncol Rep. 2011;25(6):1495\u2013502.","journal-title":"Oncol Rep"},{"issue":"26","key":"1370_CR9","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1182\/blood-2014-10-608133","volume":"125","author":"F Miraki-Moud","year":"2015","unstructured":"Miraki-Moud F, Ghazaly E, Ariza-McNaughton L, Hodby KA, Clear A, Anjos-Afonso F, et al. Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo. Blood. 2015;125(26):4060\u20138.","journal-title":"Blood"},{"issue":"3","key":"1370_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/cb900267j","volume":"5","author":"EM Stone","year":"2010","unstructured":"Stone EM, Glazer ES, Chantranupong L, Cherukuri P, Breece RM, Tierney DL, et al. Replacing Mn2+ with Co2+ in human arginase i enhances cytotoxicity towards L-Arginine auxotrophic cancer cell lines. ACS Chem Biol. 2010;5(3):333\u201342.","journal-title":"ACS Chem Biol"},{"issue":"3","key":"1370_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1593\/tlo.10265","volume":"4","author":"ES Glazer","year":"2011","unstructured":"Glazer ES, Stone EM, Zhu C, Massey KL, Hamir AN, Curley SA. Bioengineered human arginase i with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol. 2011;4(3):138\u201346.","journal-title":"Transl Oncol"},{"issue":"3","key":"1370_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nrd1033","volume":"2","author":"JM Harris","year":"2003","unstructured":"Harris JM, Chess RB. Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov. 2003;2(3):214\u201321.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"1370_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.leukres.2013.08.007","volume":"37","author":"R Tanios","year":"2013","unstructured":"Tanios R, Bekdash A, Kassab E, Stone E, Georgiou G, Frankel AE, et al. Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leuk Res. 2013;37(11):1565\u201371.","journal-title":"Leuk Res"},{"issue":"4","key":"1370_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.18632\/oncotarget.135","volume":"1","author":"MT Kuo","year":"2010","unstructured":"Kuo MT, Savaraj N, Feun LG. Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes. Oncotarget. 2010;1(4):246\u201351.","journal-title":"Oncotarget"},{"issue":"5","key":"1370_CR15","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s10637-019-00883-4","volume":"38","author":"N Khalil","year":"2020","unstructured":"Khalil N, Abi-Habib RJ. [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells. Invest New Drugs. 2020;38(5):1236\u201346.","journal-title":"Invest New Drugs"},{"issue":"23","key":"1370_CR16","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.3390\/ijms20236018","volume":"20","author":"H Al-Koussa","year":"2019","unstructured":"Al-Koussa H, Al-Haddad M, Abi-Habib R, El-Sibai M. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits colorectal cancer cell migration and invasion. Int J Mol Sci. 2019;20(23):6018.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1370_CR17","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s13577-020-00437-4","volume":"34","author":"M Swayden","year":"2021","unstructured":"Swayden M, Bekdash A, Fakhoury I, El-Atat O, Borjac-Natour J, El-Sibai M, et al. Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells. Hum Cell. 2021;34(1):152\u201364.","journal-title":"Hum Cell"},{"issue":"1","key":"1370_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","volume":"67","author":"PNM Cheng","year":"2007","unstructured":"Cheng PNM, Lam TL, Lam WM, Tsui SM, Cheng AWM, Lo WH, et al. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res. 2007;67(1):309\u201317.","journal-title":"Cancer Res"},{"issue":"1","key":"1370_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10637-019-00756-w","volume":"38","author":"G Nasreddine","year":"2020","unstructured":"Nasreddine G, El-Sibai M, Abi-Habib RJ. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent. Invest New Drugs. 2020;38(1):10\u20139.","journal-title":"Invest New Drugs"},{"issue":"Suppl 9(6)","key":"1370_CR20","first-page":"28","volume":"25","author":"SL Leung","year":"2019","unstructured":"Leung SL, Ho MK, Lam YM, Chow HY, So YH, Leung YC. PEGylated recombinant human arginase as a drug for breast cancer. Hong Kong Med J Xianggang Yi Xue Za Zhi. 2019;25(Suppl 9(6)):28\u201331.","journal-title":"Hong Kong Med J Xianggang Yi Xue Za Zhi"},{"issue":"12","key":"1370_CR21","doi-asserted-by":"publisher","first-page":"e1563","DOI":"10.1038\/cddis.2014.503","volume":"5","author":"Z Wang","year":"2014","unstructured":"Wang Z, Shi X, Li Y, Fan J, Zeng X, Xian Z, et al. Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells. Cell Death Dis. 2014;5(12):e1563\u2013e1563.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1370_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-014-1698-5","volume":"122","author":"O Khoury","year":"2015","unstructured":"Khoury O, Ghazale N, Stone E, El-Sibai M, Frankel AE, Abi-Habib RJ. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. J Neurooncol. 2015;122(1):75\u201385.","journal-title":"J Neurooncol"},{"issue":"4","key":"1370_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ijc.22322","volume":"120","author":"CY Yoon","year":"2007","unstructured":"Yoon CY, Shim YJ, Kim EH, Lee JH, Won NH, Kim JH, et al. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int J Cancer. 2007;120(4):897\u2013905.","journal-title":"Int J Cancer"},{"issue":"5","key":"1370_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1756-8722-5-17","volume":"30","author":"EC Hsueh","year":"2012","unstructured":"Hsueh EC, Knebel SM, Lo WH, Leung YC, Cheng PNM, Hsueh CT. Deprivation of arginine by recombinant human arginase in prostate cancer cells. J Hematol OncolJ Hematol Oncol. 2012;30(5):17.","journal-title":"J Hematol OncolJ Hematol Oncol"},{"issue":"15","key":"1370_CR25","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1200\/jco.2011.29.15_suppl.10627","volume":"29","author":"V Dinh","year":"2011","unstructured":"Dinh V, You M, Savaraj N, Wu C, Kuo MT, Wangpaichitr M, et al. Determining argininosuccinate synthetase (ASS) expression in patients with melanoma treated with arginine depleting therapy. J Clin Oncol. 2011;29(15):10627\u201310627.","journal-title":"J Clin Oncol."},{"key":"1370_CR26","unstructured":"Results Submitted | A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS | ClinicalTrials.gov [Internet]. [cited 2024 Aug 9]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02732184?tab=results"},{"issue":"15","key":"1370_CR27","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2014-09-600643","volume":"125","author":"F Mussai","year":"2015","unstructured":"Mussai F, Egan S, Higginbotham-Jones J, Perry T, Beggs A, Odintsova E, et al. Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target. Blood. 2015;125(15):2386\u201396.","journal-title":"Blood"},{"issue":"11","key":"1370_CR28","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1158\/1535-7163.MCT-21-0120","volume":"20","author":"Y Cai","year":"2021","unstructured":"Cai Y, Chow JPH, Leung YO, Lu X, Yuen CH, Lee WL, et al. NEI-01-Induced arginine deprivation has potent activity against acute myeloid leukemia cells both in vitro and in vivo. Mol Cancer Ther. 2021;20(11):2218\u201327.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1370_CR29","doi-asserted-by":"publisher","first-page":"11253","DOI":"10.1038\/s41598-017-10542-4","volume":"7","author":"HJ Tsai","year":"2017","unstructured":"Tsai HJ, Jiang SS, Hung WC, Borthakur G, Lin SF, Pemmaraju N, et al. A Phase II study of arginine deiminase (ADI-PEG20) in relapsed\/refractory or poor-risk acute myeloid leukemia patients. Sci Rep. 2017;7(1):11253.","journal-title":"Sci Rep"},{"issue":"9","key":"1370_CR30","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1002\/cam4.3871","volume":"10","author":"HJ Tsai","year":"2021","unstructured":"Tsai HJ, Hsiao HH, Hsu YT, Liu YC, Kao HW, Liu TC, et al. Phase I study of ADI-PEG20 plus low-dose cytarabine for the treatment of Acute Myeloid Leukemia. Cancer Med. 2021;10(9):2946\u201355.","journal-title":"Cancer Med"},{"issue":"39","key":"1370_CR31","doi-asserted-by":"publisher","first-page":"14147","DOI":"10.1073\/pnas.1404171111","volume":"111","author":"CA Changou","year":"2014","unstructured":"Changou CA, Chen YR, Xing L, Yen Y, Chuang FYS, Cheng RH, et al. Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy. Proc Natl Acad Sci U S A. 2014;111(39):14147\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1370_CR32","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1038\/cddis.2012.197","volume":"4","author":"N Syed","year":"2013","unstructured":"Syed N, Langer J, Janczar K, Singh P, Lo Nigro C, Lattanzio L, et al. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in Glioblastoma. Cell Death Dis. 2013;4(1):e458\u2013e458.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1370_CR33","doi-asserted-by":"publisher","first-page":"F244","DOI":"10.1152\/ajprenal.00033.2009","volume":"297","author":"S Periyasamy-Thandavan","year":"2009","unstructured":"Periyasamy-Thandavan S, Jiang M, Schoenlein P, Dong Z. Autophagy: molecular machinery, regulation, and implications for renal pathophysiology. Am J Physiol - Ren Physiol. 2009;297(2):F244\u201356.","journal-title":"Am J Physiol - Ren Physiol"},{"issue":"10","key":"1370_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.232","volume":"7","author":"GR Bean","year":"2016","unstructured":"Bean GR, Kremer JC, Prudner BC, Schenone AD, Yao JC, Schultze MB, et al. A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient Sarcomas. Cell Death Dis. 2016;7(10):e2406.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1370_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/0008-5472.CAN-08-3157","volume":"69","author":"RH Kim","year":"2009","unstructured":"Kim RH, Coates JM, Bowles TL, McNerney GP, Sutcliffe J, Jung JU, et al. Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res. 2009;69(2):700\u20138.","journal-title":"Cancer Res"},{"issue":"12","key":"1370_CR36","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1002\/ijc.25202","volume":"126","author":"B Delage","year":"2010","unstructured":"Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T, et al. Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer. 2010;126(12):2762\u201372.","journal-title":"Int J Cancer"},{"issue":"20","key":"1370_CR37","doi-asserted-by":"publisher","first-page":"8487","DOI":"10.1007\/s00253-015-6565-6","volume":"99","author":"C Lin","year":"2015","unstructured":"Lin C, Wang Z, Li L, He Y, Fan J, Liu Z, et al. The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma. Appl Microbiol Biotechnol. 2015;99(20):8487\u201394.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"40","key":"1370_CR38","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.1038\/onc.2014.458","volume":"34","author":"S Fulda","year":"2015","unstructured":"Fulda S, K\u00f6gel D. Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy. Oncogene. 2015;34(40):5105\u201313.","journal-title":"Oncogene"},{"issue":"12","key":"1370_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.redox.2017.02.017","volume":"24","author":"J Xu","year":"2017","unstructured":"Xu J, Wu Y, Lu G, Xie S, Ma Z, Chen Z, et al. Importance of ROS-mediated autophagy in determining apoptotic cell death induced by physapubescin B. Redox Biol. 2017;24(12):198\u2013207.","journal-title":"Redox Biol"},{"issue":"1","key":"1370_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3892\/or.2014.3556","volume":"33","author":"YS Shan","year":"2015","unstructured":"Shan YS, Hsu HP, Lai MD, Yen MC, Luo YP, Chen YL. Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer. Oncol Rep. 2015;33(1):49\u201357.","journal-title":"Oncol Rep"},{"issue":"8","key":"1370_CR41","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3389\/fimmu.2017.00864","volume":"24","author":"A Werner","year":"2017","unstructured":"Werner A, Koschke M, Leuchtner N, Luckner-Minden C, Habermeier A, Rupp J, et al. Reconstitution of T Cell proliferation under arginine limitation: activated human t cells take up citrulline via l-type amino acid transporter 1 and use it to regenerate arginine after induction of argininosuccinate synthase expression. Front Immunol. 2017;24(8):864.","journal-title":"Front Immunol"},{"issue":"9","key":"1370_CR42","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/bjc.2012.106","volume":"106","author":"LG Feun","year":"2012","unstructured":"Feun LG, Marini A, Walker G, Elgart G, Moffat F, Rodgers SE, et al. Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase. Br J Cancer. 2012;106(9):1481\u20135.","journal-title":"Br J Cancer"},{"issue":"1","key":"1370_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/cjp2.4","volume":"1","author":"DJ Cheon","year":"2015","unstructured":"Cheon DJ, Walts AE, Beach JA, Lester J, Bomalaski JS, Walsh CS, et al. Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas. J Pathol Clin Res. 2015;1(1):41\u201353.","journal-title":"J Pathol Clin Res"},{"issue":"2","key":"1370_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S030-43835(02)00693-6","volume":"191","author":"LJ Shen","year":"2003","unstructured":"Shen LJ, Lin WC, Beloussow K, Shen WC. Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett. 2003;191(2):165\u201370.","journal-title":"Cancer Lett"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01370-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01370-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:04:54Z","timestamp":1774875894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01370-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1370"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01370-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8358552\/v1","asserted-by":"object"}]},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests or conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not involve the use animals. This study does not involve the participation of human subjects nor the use patient data. Hence, ethics approval and consent to participate are not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All the authors have given consent for the publication of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"55"}}